Wednesday, July 11, 2018

DermWire TV: BrightGuard Covers NYC, Galderma Uncovers Rosacea Burden, Dermira's Qbrexza Approved

BrightGuard dispensers have now been installed at 53 public pools and 11 beaches in various locations throughout metropolitan New York. The impact of rosacea can be significant for affected patients. According to survey results released last month by Galderma, 86% of patients with rosacea modify their behavior in attempts to manage disease symptoms, and more than half say the disease has impacted their work productivity. The FDA has approved Qbrexza cloth (glycopyrronium) from Dermira for the topical treatment of primary axillary hyperhidrosis in patients 9 years of age and older.

Watch Video

Thursday, June 28, 2018

DermWireTV: New eRelevance Services, Cosmetic Bootcamp Updates, Leo & AID Partnership

eRelevance has launched a suite of 4 services intended to support aesthetic practices in optimizing their marketing strategies to capture, convert, and retain patients. CEO Bob Fabbio discusses. Aesthetic education takes center stage at Cosmetic Boot Camp in Aspen. The meeting is open only to board certified physicians from the 4 core specialities and is focused on optimizing aesthetic outcomes. Doris Day, MD, Tina Alster, MD, Mary Lupo, MD, and Vic Narurkar, MD weigh in. Leo Pharma and its Boston-based R&D innovation unit LEO Science & Tech Hub are joining forces with Advancing Innovation in Dermatology.

Watch Video

Thursday, June 07, 2018

DermWire TV: Skin Cancer Perceptions, Cimzia for Psoriasis, Eczema and CV Risk

A new national survey, Skin Cancer In America 2018, conducted by Health Union, explores perceptions of patients with skin cancer. Cimzia (certolizumab pegol, UCB) has received FDA approval for treatment of adults with moderate to severe plaque psoriasis. Cimzia is the first Fc-free, PEGylated anti TNF approved for psoriasis. There is now evidence that, like psoriasis and rosacea, eczema may be linked to cardiovascular risk. Spironolactone may be just as effective as antibiotics for the treatment of women with acne, researchers from the Perelman School of Medicine at the University of Pennsylvania report.

Watch Video

Thursday, May 24, 2018

DermWireTV: Sunscreen Ratings, Restylane Lyft for Hands, NPF, SCF News

Both Consumer Reports and the Environmental Working Group have issued sunscreen rankings, and while some products shine, many products may underperform. FDA issued warnings to several companies illegally marketing dietary supplements that make unproven drug claims about protecting consumers from sun exposure. Restylane Lyft has become the first hyaluronic acid filler to receive FDA approval for use on the dorsal hands of people older than 21. Jerry Bagel, MD will receive the Excellence in Leadership Award from the National Psoriasis Foundation next month. The Skin Cancer Foundation has kicked off the second year of its mobile education and screening program called Destination: Healthy Skin.

Watch Video

Thursday, May 10, 2018

DermWireTV: Skin Cancer Awareness, Epiduo Data, Impoyz Launch

Data shed light on patents’ attitudes towards kids’ sunblock and new findings emerge on melanoma risks. FDA accepts BLA for cemiplimab for advanced SCC and approves Novartis’ Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations. Data highlight clinical experience with Epiduo Forte Gel. Encore Dermatology launches Impoyz Cream.

Watch Video

Tuesday, April 10, 2018

DermWireTV: Indiana Gets SUNucated, Dr. Joel Cohen Honored, Rosacea Awareness

Indiana is the first state in 2018 to give children broader access to sunscreen at school through the SUNucation Initiative. The Indiana Academy of Dermatology, with a grant from the American Society for Dermatologic Surgery Association, helped successfully pass the legislation. Joel L. Cohen, MD of About Skin Dermatology in Lone Tree and Englewood, CO will receive the Humanitarian Award at the Melanoma Research Foundation’s Wings of Hope for Melanoma gala this month in Denver. April is rosacea awareness month, and the National Rosacea Society is once again trying to improve education about the condition, its diagnosis, and treatment. More than half of millennials say they don’t trust social media and just 10 percent say celebrity endorsements influence their decision to have a cosmetic procedure, a new ZALEA survey finds.

Watch Video

Wednesday, March 28, 2018

DermWireTV: ABD Eyes Mohs Certification, Sun's Ilumya Approved, FUE Update

The American Board of Dermatology has notified the American Board of Medical Specialties it wants to offer a subspecialty certificate in Micrographic Dermatologic Surgery. Dermatologists react. Ilumya or tildrakizumab from Sun Pharma is approved for moderate to severe psoriasis. Medicine the Musical could be coming to off-broadway this fall. And there’s a dermatologist to thank for it. The International Society of Hair Restoration Surgery has updated the terminology of the hair transplantation method known as FUE from Follicular Unit Extraction to Follicular Unit Excision. EDITOR'S NOTE: The initial broadcast incorrectly reported 28-week placebo data for Ilumya. Placebo data were only reported for Week 64.

Watch Video

Thursday, March 08, 2018

DermWireTV: NPF Services, Eskata Update, AAD Meeting Data

The National Psoriasis Foundation is expanding its services to patients, with a special focus on teens affected by the Skin Disease. Widely anticipated by both physicians and patients, Eskata will be available for in-office use this spring. Aclaris CEO, Dr. Neal Walker addresses the launch, as well as the pipeline for Aclaris. A look at some of the new data presented at the AAD Annual Meeting in San Diego. And, step inside Differin's Retinoid Education Week.

Watch Video

Wednesday, February 21, 2018

Updates from the AAD Annual Meeting in San Diego

From cosmetic interventions to therapeutic breakthroughs for common dermatoses, and new technologies for practice, the latest innovations take center stage at the 2018 Annual Meeting of the American Academy of Dermatology. Joel L. Cohen, MD; Yolanda Lenzy, MD, MPH; Junko Takeshita, MD, PhD, MSCE; and Daniel P. Friedmann, MD offer updates.

Watch Video

Wednesday, February 07, 2018

DermWireTV: Allergan's Cool Campaign, Obagi Line Launches, Apple Upgrades Health App

There’s some misleading information about fat reduction out there, and that’s not cool, Allergan says. The company's CoolSculpting device has launched the “Not Cool Vs. Cool” campaign. Data show patients and doctors assess scars differently: Patients tend to focus on scar depth, while physicians focus on scar pigmentation and relief. An update to Apple's Health App gives customers access to their medical records on their iPhone. Obagi Medical has launched the SUZANOBAGIMD product line.

Watch Video

Thursday, January 25, 2018

DermWireTV: Eczema Discovery; Ortho Dermatologics, Revision, Alastin Product Launches

Regeneron revealed that Dupixent generated sales of $120M within the first nine months of launch. Researchers have identified a possible treatment for moderate-to-severe atopic dermatitis: IL-22 blockade. Product launches or updates from Revision Skincare, Alastin Skincare, Ortho Dermatologics, and Intraderm. Adam Friedman, MD has been awarded the Innovations in Residency Training Award at the Orlando Dermatology Aesthetic & Clinical Conference (ODAC). And introducing DermWire News for smart speaker: Alexa, play Dermatology News.

Watch Video

Thursday, January 11, 2018

DermWireTV: Two Launches from Cutera, AmSpa Projections

Cutera introduces two new devices to its laser and energy-based device offerings: Juliet laser represents Cutera’s first entry into the women’s health segment of the aesthetics market; Secret RF is a new fractional radio frequency microneedling device that effectively remodels collagen, improves mild wrinkles, and diminishes scars. MedSpa revenues are growing at a double-digit pace since 2010, and younger generations seem to be driving the boom, a new American Med Spa Association (AmSpa) study shows. Researchers are developing an antibiotic patch that can bypass the gut bacteria and extend the useful lifespan of currently-available antibiotics. DermTech Canada, a licensee of DermTech, has received approval to market DermTech’s Pigmented Lesions Assay (PLA) and non-invasive biopsy kit for the detection of melanoma in Canada.

Watch Video
Load More